Prot# ML18124: A Prospective, Randomized, Multicenter, Open-Label, Comparative Safety & Efficacy Study of Prophylactically Administered Pegylated Interferon alfa-2a (Pegasys®) + Ribavirin vs. No Prophylaxis Following Liver Transplantation for Hepatitis C

Project: Research project

Project Details

StatusFinished
Effective start/end date2/4/0511/1/11

Funding

  • Roche Laboratories Inc. (ML18124)